As Foot Locker (FL) Share Value Declined, Lsv Asset Management Has Lowered Stake by $710,500; Cvs Health Corp. (CVS) Holder Armstrong Shaw Associates Decreased Position as Valuation Declined

December 21, 2017 - By Maria Brooks

Lsv Asset Management decreased its stake in Foot Locker Inc. (FL) by 1.81% based on its latest 2017Q3 regulatory filing with the SEC. Lsv Asset Management sold 20,300 shares as the company’s stock declined 17.30% while stock markets rallied. The institutional investor held 1.10M shares of the consumer services company at the end of 2017Q3, valued at $38.85 million, down from 1.12 million at the end of the previous reported quarter. Lsv Asset Management who had been investing in Foot Locker Inc. for a number of months, seems to be less bullish one the $5.82B market cap company. The stock increased 3.65% or $1.69 during the last trading session, reaching $47.98. About 4.04 million shares traded. Foot Locker, Inc. (NYSE:FL) has risen 0.29% since December 21, 2016 and is uptrending. It has underperformed by 16.41% the S&P500.

Armstrong Shaw Associates Inc decreased its stake in Cvs Health Corp. (CVS) by 58.25% based on its latest 2017Q3 regulatory filing with the SEC. Armstrong Shaw Associates Inc sold 54,023 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 38,715 shares of the medical and nursing services company at the end of 2017Q3, valued at $3.15 million, down from 92,738 at the end of the previous reported quarter. Armstrong Shaw Associates Inc who had been investing in Cvs Health Corp. for a number of months, seems to be less bullish one the $75.62 billion market cap company. The stock increased 1.47% or $1.08 during the last trading session, reaching $74.64. About 10.51M shares traded or 11.56% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since December 21, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment decreased to 0.81 in 2017 Q3. Its down 0.06, from 0.87 in 2017Q2. It is negative, as 100 investors sold FL shares while 131 reduced holdings. 56 funds opened positions while 132 raised stakes. 106.03 million shares or 8.40% less from 115.75 million shares in 2017Q2 were reported. New Amsterdam Prtnrs Ltd Co New York holds 0.26% or 35,468 shares in its portfolio. Eads Heald Inv Counsel accumulated 0.18% or 8,257 shares. Next Finance Gru Inc reported 0.01% in Foot Locker, Inc. (NYSE:FL). Cibc Asset Mgmt, Ontario – Canada-based fund reported 17,656 shares. Metropolitan Life Communication New York stated it has 0.01% of its portfolio in Foot Locker, Inc. (NYSE:FL). 8,443 are owned by Intrust National Bank & Trust Na. State Teachers Retirement System invested in 258,056 shares. Logan accumulated 179,220 shares or 0.45% of the stock. Two Sigma Ltd Co has invested 0.07% of its portfolio in Foot Locker, Inc. (NYSE:FL). Tompkins Financial has invested 0% in Foot Locker, Inc. (NYSE:FL). British Columbia Invest Mgmt Corporation holds 92,617 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.01% or 34,648 shares. Brandywine Mngmt Lc reported 88 shares. Arrowstreet Capital Lp holds 0% or 15,900 shares in its portfolio. Asset Mngmt holds 0.01% or 12,460 shares.

Lsv Asset Management, which manages about $82.68B and $60.63 billion US Long portfolio, upped its stake in Dime Community Bancshares Inc. (NASDAQ:DCOM) by 145,049 shares to 1.21M shares, valued at $26.07M in 2017Q3, according to the filing. It also increased its holding in Triumph Group Inc. (NYSE:TGI) by 80,100 shares in the quarter, for a total of 2.57 million shares, and has risen its stake in Tenneco Inc. (NYSE:TEN).

Among 30 analysts covering Foot Locker Inc. (NYSE:FL), 13 have Buy rating, 1 Sell and 16 Hold. Therefore 43% are positive. Foot Locker Inc. had 114 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Buckingham Research on Tuesday, November 10 to “Neutral”. The firm earned “Hold” rating on Friday, August 18 by Canaccord Genuity. The company was downgraded on Monday, October 23 by Buckingham Research. The rating was maintained by Canaccord Genuity with “Hold” on Wednesday, November 15. The stock of Foot Locker, Inc. (NYSE:FL) has “Hold” rating given on Wednesday, October 18 by Canaccord Genuity. The stock of Foot Locker, Inc. (NYSE:FL) has “Hold” rating given on Thursday, July 6 by Oppenheimer. The company was maintained on Friday, October 27 by Robert W. Baird. On Friday, August 18 the stock rating was downgraded by Telsey Advisory Group to “Market Perform”. The company was downgraded on Friday, August 18 by JP Morgan. UBS maintained Foot Locker, Inc. (NYSE:FL) on Wednesday, July 22 with “Buy” rating.

Analysts await Foot Locker, Inc. (NYSE:FL) to report earnings on February, 23. They expect $1.23 EPS, down 10.22% or $0.14 from last year’s $1.37 per share. FL’s profit will be $149.07M for 9.75 P/E if the $1.23 EPS becomes a reality. After $0.87 actual EPS reported by Foot Locker, Inc. for the previous quarter, Wall Street now forecasts 41.38% EPS growth.

Since August 16, 2017, it had 0 buys, and 7 selling transactions for $58.32 million activity. $199,050 worth of CVS Health Corporation (NYSE:CVS) was sold by SWIFT RICHARD J on Wednesday, August 16. The insider MERLO LARRY J sold 241,150 shares worth $20.03M. Another trade for 237,078 shares valued at $18.88M was sold by Denton David M. Roberts Jonathan C had sold 85,743 shares worth $7.13M. Foulkes Helena had sold 39,340 shares worth $3.22 million on Friday, September 15.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. 83,877 were reported by Putnam Fl Company. Moreover, Century has 0.38% invested in CVS Health Corporation (NYSE:CVS) for 4.62 million shares. Asset Corp holds 7,600 shares or 0.11% of its portfolio. Montag A Associate holds 0.39% or 44,167 shares. First Trust holds 0.22% in CVS Health Corporation (NYSE:CVS) or 23,474 shares. South Street Advisors Limited Liability Company stated it has 2,880 shares. 58,894 were reported by Amica Pension Fund Board Of Trustees. Arrow accumulated 24,842 shares or 0.48% of the stock. Argi Inv Ser Ltd Com, a Kentucky-based fund reported 11,803 shares. Berkshire Asset Ltd Co Pa reported 5,388 shares. 37,331 are held by First Allied Advisory Ser Inc. Neuberger Berman Grp Inc Ltd Liability Company holds 0.26% of its portfolio in CVS Health Corporation (NYSE:CVS) for 2.60 million shares. Alps Incorporated holds 17,497 shares. Webster National Bank N A invested 0.9% of its portfolio in CVS Health Corporation (NYSE:CVS). Iowa State Bank holds 0.72% or 18,683 shares in its portfolio.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 EPS, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92 billion for 9.82 P/E if the $1.90 EPS becomes a reality. After $1.50 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 58 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Thursday, December 17 by Goldman Sachs. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The rating was maintained by Deutsche Bank on Thursday, August 20 with “Hold”. The firm earned “Buy” rating on Wednesday, August 19 by Evercore. The company was initiated on Thursday, October 6 by UBS. Barclays Capital initiated CVS Health Corporation (NYSE:CVS) on Friday, December 18 with “Overweight” rating. The firm has “Neutral” rating by Robert W. Baird given on Thursday, February 2. JP Morgan maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 2. JP Morgan has “Overweight” rating and $123 target. The firm has “Equal-Weight” rating by Morgan Stanley given on Monday, June 20. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Friday, August 28 with “Outperform” rating.